Ritlecitinib is an oral irreversible JAK3/TEC inhibitor primarily used for the treatment of immune related diseases such as alopecia areata and vitiligo.
The specification of Ritlecitinib is 50mg*28 pills/bottle, which is a common packaging specification, but other specifications may also exist, depending on the market supply situation.